CIBC World Markets’s Pulmonx LUNG Stock Holding History

CIBC World Markets’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-50,000	Closed	-$464K	–	757
2024 Q1	$464K	Buy	+50,000	New	+$586K	﹤0.01%	729

Other funds holding LUNG

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

CIBC World Markets's LUNG Position: Q2 2024 in Review

CIBC World Markets sold out of Pulmonx (LUNG) in Q2 2024, closing a stake of 50,000 shares — an estimated $464K sold.

CIBC World Markets first reported a position in LUNG in Q1 2024 and held it in 1 quarter. The position peaked at $464K in Q1 2024. 111 funds tracked by Wall St. Rank hold LUNG as of Q2 2024.

CIBC World Markets reported no remaining Pulmonx position as of Q2 2024 after selling out during the quarter.
CIBC World Markets sold 50,000 Pulmonx shares in Q2 2024, an estimated $464K.
CIBC World Markets first reported a position in Pulmonx in Q1 2024 and held it in 1 quarter.
CIBC World Markets's Pulmonx position peaked at $464K in Q1 2024.
111 funds tracked by Wall St. Rank held Pulmonx as of Q2 2024.

Based on CIBC World Markets's 13F filing for Q2 2024, filed 12 Aug 2024.